Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo

Wenxiu Qi(Peking University), Yubin Ge(Wayne State University), Wenbo Zhang(Ministry of Education Science and Technology), Roland Chu(Children's Hospital of Michigan), Holly Edwards(Wayne State University), Gerard J. Madlambayan(University of Rochester), Yue Wang(Qingdao University), Zhihong Wang(Rowan University), Jeffrey W. Taub(Wayne State University), Hai Lin(Jilin University), Chunhuai Li(Jilin University)
Cancer Biology & Therapy
November 3, 2015
10.1080/15384047.2015.1095406
Cited by 36

Related Papers

Alginate hydrogels as synthetic extracellular matrix materials
|Biomaterials|1999|2.3k
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
|The Lancet Oncology|2010|586
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer
|Cancer Cell|2018|489
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971
|Blood|2011|230
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2012|217